[KİTAP][B] RNA, the epicenter of genetic information

J Mattick, P Amaral - 2023 - library.oapen.org
The origin story and emergence of molecular biology is muddled. The early triumphs in
bacterial genetics and the complexity of animal and plant genomes complicate an intricate …

Improvement of different vaccine delivery systems for cancer therapy

A Bolhassani, S Safaiyan, S Rafati - Molecular cancer, 2011 - Springer
Cancer vaccines are the promising tools in the hands of the clinical oncologist. Many tumor-
associated antigens are excellent targets for immune therapy and vaccine design. Optimally …

Viral gene therapy strategies: from basic science to clinical application

LS Young, PF Searle, D Onion… - The Journal of …, 2006 - Wiley Online Library
A major impediment to the successful application of gene therapy for the treatment of a
range of diseases is not a paucity of therapeutic genes, but the lack of an efficient non‐toxic …

[HTML][HTML] CFTR modulators for the treatment of cystic fibrosis

RS Pettit, C Fellner - Pharmacy and Therapeutics, 2014 - ncbi.nlm.nih.gov
CFTR Modulators for the Treatment of Cystic Fibrosis - PMC Back to Top Skip to main content
NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …

Nanodelivery in airway diseases: challenges and therapeutic applications

I Roy, N Vij - Nanomedicine: Nanotechnology, Biology and Medicine, 2010 - Elsevier
This review describes the challenges and therapeutic applications of nanodelivery systems
for treatment of airway diseases. Therapeutic applications of nanodelivery in airway …

Selective gene delivery for cancer therapy using cationic liposomes: in vivo proof of applicability

CR Dass, PFM Choong - Journal of controlled release, 2006 - Elsevier
Targeted gene therapy is essential if cancer treatment is to become a reality with this form of
therapy. In the past few years, cationic liposomes, discovered 2 decades ago, and at …

Pseudomonas aeruginosa and periodontal pathogens in the oral cavity and lungs of cystic fibrosis patients: a case-control study

R Rivas Caldas, F Le Gall, K Revert… - Journal of clinical …, 2015 - Am Soc Microbiol
Cystic fibrosis (CF) is the most frequent lethal genetic disease in the Caucasian population.
Lung destruction is the principal cause of death by chronic Pseudomonas aeruginosa …

Genetic modification of the lung directed toward treatment of human disease

D Sondhi, KM Stiles, BP De, RG Crystal - Human gene therapy, 2017 - liebertpub.com
Genetic modification therapy is a promising therapeutic strategy for many diseases of the
lung intractable to other treatments. Lung gene therapy has been the subject of numerous …

Beyond cystic fibrosis transmembrane conductance regulator therapy: a perspective on gene therapy and small molecule treatment for cystic fibrosis

EK Schneider-Futschik - Gene therapy, 2019 - nature.com
Cystic fibrosis (CF) is a life-limiting disease caused by defective or deficient cystic fibrosis
transmembrane conductance regulator (CFTR) activity. The recent advent of the FDA …

Targeted gene delivery through the respiratory system: rationale for intratracheal gene transfer

MG Katz, AS Fargnoli, SM Gubara, K Fish… - Journal of …, 2019 - mdpi.com
Advances in DNA-and RNA-based technologies have made gene therapy suitable for many
lung diseases, especially those that are hereditary. The main objective of gene therapy is to …